Bacterial resistance to antibiotic alternatives: a wolf in sheep’s clothing? by Willing, Benjamin P et al.
Apr. 2018, Vol. 8, No. 2
Feature Article
Bacterial resistance to antibiotic alternatives: a 
wolf in sheep’s clothing?1
Benjamin P. Willing*, Deanna M. Pepin, Camila S. Marcolla, Andrew J. Forgie,  
Natalie E. Diether, and Benjamin C. T. Bourrie 
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta T6G 2P5, Canada
Corresponding author: willing@ualberta.ca
Key words: antibiotic alternatives, resistance mechanisms, responsible 
use
Introduction
With the growing concern of antibiotic resistance (Aminov 
and Mackie, 2007; Zaman et al., 2017), there has been a strong 
push to reduce the use of antibiotics in animal production 
systems (Van Boeckel et al., 2015; Ventola, 2015). Many anti-
biotic alternatives have been developed, with varying degrees 
of success in improving health outcomes and growth perfor-
mance (Gresse et al., 2017). These alternatives use very differ-
ent approaches to regulate both commensal and pathogenic 
bacterial populations. Antibiotic alternatives such as phage 
and bacteriocins have very clear mechanisms of antimicro-
bial activity (Figure 1), whereas others, such as essential oils/
phytosterols, have less defined modes of action. Irrespective of 
mode of action, there has been insufficient attention given to 
the ability of bacteria to develop resistance to these antibiotic 
alternatives. Considering the development of resistance will 
be essential in finding long-term solutions. In this review, we 
present what is known about the ability of bacteria to become 
resistant to these antibiotic alternatives, and more impor-
tantly, identify where they contribute to antibiotic resistance. 
Prudence is required, as avoiding further contribution to anti-
biotic resistance is necessary. This review is not exhaustive but 
is intended to give a good representation from different classes 
of antibiotic alternatives. In particular, we focus on phage, 
essential oils, direct-fed microbials and bacteriocins, metals 
and minerals, and organic acids. Some consideration is given to 
their application, effectiveness, and modes of action.
Bacteriophages
Bacteriophages are viruses that can infect and kill bacteria. 
In the environment, there is a constant arms race between bac-
teria and phages: as bacteria develop resistance mechanisms, 
new phages emerge. Bacteriophages are highly specific, which 
makes them intriguing antibiotic alternatives as they are less 
likely to affect commensal bacteria. Although, bacteriophages 
have not yet been widely adopted in animal production sys-
tems, they have been shown to be effective in controlling path-
ogenic bacteria in feed animals. Research has shown potential 
for phages to control colonization of Campylobacter jejuni 
(Carrillo et  al., 2005), and Salmonella (Borie et  al., 2008; 
Bardina et  al., 2012), while decreasing mortality in chickens 
during Escherichia coli infection (Huff et al., 2002; Huff et al., 
2006). Phages have also been effective in reducing Salmonella 
shedding in pigs (Saez et al., 2011) and reducing shedding of 
E. coli O157:H7 in sheep (Bach et al., 2009; Raya et al., 2011). 
However, efforts targeting E.  coli O157 in cattle have proven 
to be less successful (Rozema et al., 2009; Rivas et al., 2010; 
Stanford et al., 2010).
While phages present potential for the control of patho-
genic bacteria, there are significant considerations still required 
regarding their implementation in animal production. As with 
antibiotics, bacteria are capable of developing resistance to 
phage infection utilizing systems such as the Clustered Regularly 
Interspaced Short Palindromic Repeat (CRISPR) system as a 
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• Substantial pressure to reduce antibiotic use has necessitated 
the development of antibiotic alternatives. However, relatively 
little consideration has been given to the development of 
resistance to these alternatives.
• Whether we come up with antibiotic alternatives that are bac-
teriocidal or inhibitory, bacteria will continue to adapt and 
evolve.
• Some antibiotic alternatives support the development of anti-
biotic resistance necessitating caution.
• There are opportunities to optimize antibiotic alternative 
effectiveness as well as to minimize the development of resist-
ance mechanisms.
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pseudoimmune system, or the abortive infection system to kill 
infected cells before the phage can spread (Labrie et al., 2010). 
Additionally, bacteria can alter their cell surface to remove or 
block the receptor to which the phage binds (Labrie et al., 2010), 
which can impact virulence or colonization factors (Cryz et al., 
1984). For example, the occurrence of phage-resistant C. jejuni 
has been noted; however, all isolates exhibited decreased ability 
to colonize the cecum of broiler chickens (Carrillo et al., 2005). 
As resistance to multiple phages can be difficult for bacteria to 
develop, the use of phage cocktails which target different recep-
tors is recommended. This has been shown to result in superior 
reduction of bacterial cells with fewer incidence of resistant 
strains and is commonly used in studies examining phage treat-
ment (Huff et al., 2002; Carrillo et al., 2005; Rivas et al., 2010).
Another factor to consider in the use of phages is the charac-
teristics of the phages themselves. Phages can be both lytic and 
lysogenic in nature, with only lytic phages being appropriate for 
phage treatment. This is due to the fact that lysogenic phages do 
not always result in lytic infection, leaving some bacteria alive 
with the phage genome inserted into their own. Additionally, 
lysogenic phages are capable of contributing to the transfer of 
antibiotic resistance and virulence genes across bacterial pop-
ulations (Wagner and Waldor, 2002; Balcazar, 2014). Because 
of these factors, in addition to utilizing cocktails of phages to 
prevent the development of resistance, it is important that all 
phages to be used for treatment or prophylaxis in animal pro-
duction be thoroughly tested to ensure purely lytic infections 
can occur with their use.
Antibacterial Metals, Minerals, and Nanoparticles
Unlike phage, metals including Copper (Cu2+/Cu+), Zinc 
(Zn2+), and Silver (Ag+), and nonmetal elements, such as Iodine 
(I2), have been used in animal production for their broad-spec-
trum antibacterial activity and low generation of resistance 
(Aarestrup and Hasman, 2004; Murdoch and Lagan, 2013; 
Wang et  al., 2016). Copper, zinc, and silver disrupt bacterial 
protein functions, generate reactive oxygen species, and cause 
damage to bacterial DNA (Rosen, 2002; Xiu et  al., 2014). 
Although iodine’s antimicrobial activity is not well understood, 
there is indication that it works by reacting with unsaturated 
fatty acids in the lipid bilayer of the cell wall to cause leaks, 
Figure 1. (A) Phage interact with specific receptors to inject DNA into the bacterial cell, causing viral proliferation and cell lysi (i). Essential oils (EOs) disrupt 
efflux/influx, membrane receptors and stability (ii). Copper disrupts bacterial lipids, proteins, and DNA through oxidization (iii). Bacteriocins cause cell wall 
lysis, disrupt the plasma membrane structure (pore formation), and interfere with DNA function (iv). (B) Bacterial resistance to phage is conferred through 
either blockage/removal of the receptor or cutting of phage DNA in the cell by CRISPR/CAS (i). Bacteria form aggregates to minimize cell surface exposure to 
EOs, thus preventing membrane associated disruptions (ii). Glutathione chelates Cu+, ATPase efflux system exports Cu+/Cu2+, and siderophores sequester Cu2+ 
to prevent it entering the cell (iii). Modifications of the cell wall and membrane affect fluidity and charge, impairing bacteriocin binding (iv).
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as well as inactivating nuclear materials through coagulation 
(Murdoch and Lagan, 2013). As a result of their broad-spec-
trum antimicrobial activity, it was believed that generation of 
bacterial resistance to Cu2+, Zn2+, Ag+, and I2 should be low 
(Martínez-Abad et al., 2012; Murdoch and Lagan, 2013; Wang 
et al., 2016).
Copper and Zinc salts are commonly added to animal 
feeds in concentrations above dietary requirements because 
of their antimicrobial activity, which results in reduced infec-
tion and improved animal growth. Similarly, Zinc Oxide added 
to pig diets has been effective in reducing post-weaning diar-
rhea (Mazaheri Nezhad Fard et al., 2011; Pieper et al., 2012; 
Holman and Chénier, 2015; Vahjen et al., 2015). Additionally, 
copper has been determined to be an effective antimicrobial for 
udder washes, proving active against a panel of bacteria and 
yeasts associated with bovine mastitis (Reyes-Jara et al., 2016). 
The antimicrobial properties of copper and zinc when added to 
feed have created a selective pressure for bacteria that contain 
resistance to these heavy metals (Mazaheri Nezhad Fard et al., 
2011). High inclusion rates alter the gut microbiome, however, 
many bacteria have developed resistance, with both zinc- and 
copper-resistant enterococci identified from the gut microbi-
ome of pigs (Mazaheri Nezhad Fard et al., 2011; Pieper et al., 
2012; Vahjen et  al., 2015). Bacterial resistance genes to zinc 
and copper are located on mobile genetic elements, often plas-
mids, which are transferable between bacteria (Aarestrup and 
Hasman, 2004; Mazaheri Nezhad Fard et  al., 2011; Richard 
et al., 2017).
More importantly, bacteria resistant to copper and zinc have 
indicated increased resistance to antibiotics, as an increased 
dose of dietary zinc oxide in weaned pigs increased tetracycline 
and sulfonamide resistance genes (Mazaheri Nezhad Fard 
et al., 2011; Vahjen et al., 2015). This increase in resistance is 
likely due to mechanisms of cross-resistance or coresistance: 
when microbes use the same resistance mechanism to defend 
against different antimicrobials such as an efflux pump, or 
when the genes responsible for resistance are linked closely and 
are transcribed or transferred together (El Behiry et al., 2012; 
Vahjen et al., 2015; Reyes-Jara et al., 2016). The genes associ-
ated with resistance to copper and zinc have been found on the 
same plasmids that contain antibiotic resistance genes, and the 
selective pressure of these metals can result in the sharing of 
antibiotic resistance among bacteria (Mazaheri Nezhad Fard 
et al., 2011; Yin et al., 2017), as depicted in Figure 2.
Silver and iodine have been used for many years as antimicro-
bial agents for wounds and external infections because of their 
broad-spectrum activity against bacteria and low development 
of resistance (Martínez-Abad et  al., 2012; Murdoch and 
Lagan, 2013; Kalan et al., 2017). Iodine and silver are active 
antimicrobial ingredients used in both human and animal 
wound care products (Burks, 1998; Murdoch and Lagan, 2013; 
Kalan et al., 2017), and iodine has commonly been used as an 
udder wash (Tremblay et al., 2014).
Extracellular polymeric substances found in biofilms con-
tain functional groups capable of binding metal ions, like silver, 
and protect against antimicrobial agents such as iodine (Kang 
et  al., 2014; Tremblay et  al., 2014; Xiu et  al., 2014). Other 
defenses include mechanisms against oxidative stress, protein/
DNA damage repair mechanisms, and metal efflux pumps 
(Gupta et  al., 1999; Tremblay et  al., 2014; Xiu et  al., 2014). 
However, studies have shown that silver is capable of penetrat-
ing and killing biofilms (Heidari Zare et al., 2017; Kalan et al., 
2017; Lemire et  al., 2017) and multidrug-resistant pathogens 
(Kalan et al., 2017).
Recent research has indicated that silver resistance is due to 
the Sil operon that resides on plasmid pMG101 identified in 
Salmonella enterica serovar Typhimurium, which when trans-
ferred to E. coli, conferred silver resistance (Woods et al., 2009; 
Asiani et al., 2016). Plasmid pMG101 also contains resistance 
genes to a list of antibiotics, including ampicillin, chloram-
phenicol, tetracycline, streptomycin, and sulphonamide, sug-
gesting that the transfer of pMG101 between bacteria under 
the selective pressure of silver may also result in sharing of 
other antibiotic resistance (Woods et al., 2009). However, inci-
dence of silver resistance remains low (Woods et  al., 2009; 
Kalan et al., 2017) which may indicate that plasmid pMG101 
is restricted to particular species or is difficult to transfer or be 
maintained by other bacteria (Woods et al., 2009).
Up until 2013, no known generation of bacterial resistance 
to iodine had been identified, and studies looking at repeated 
iodine use over time did not indicate any increase in resistant 
bacteria (Murdoch and Lagan, 2013). Mastitis-associated bac-
teria have shown to produce biofilms to survive treatment with 
low concentrations of iodine (Tremblay et  al., 2014). Using 
sublethal concentrations of nonoxinol-9 iodine complex on 
Staphylococcus aureus strains specific to mastitis resulted in the 
development of resistance, although the mechanisms of tol-
erance are unknown (El Behiry et al., 2012). Although other 
research has indicated cross-resistance of antibiotics with other 
biocides (El Behiry et al., 2012), currently there is no known 
cross-resistance with iodine and antibiotics (El Behiry et  al., 
2012; Murdoch and Lagan, 2013).
Given the challenges with feeding high dose metals, in 
particular, bacterial resistance and environmental effects 
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of run-off, metal nanoparticles have gained attention as an 
alternative (Yin et  al., 2017). Metal nanoparticles such as 
silver, copper oxide, and zinc oxide are of  particular inter-
est for their antimicrobial properties and suitability as feed 
additives (Beyth et  al., 2015). Technological advances have 
decreased the cost of  synthesizing nanoparticles and made 
their inclusion in livestock diets more feasible in recent years 
(Fondevila et al., 2009). The mode of  action for antimicrobial 
metal nanoparticles is not completely elucidated; potential 
mechanisms include cell membrane disruption, generation of 
reactive oxygen species, and disruption of  protein structure 
(Beyth et  al., 2015). The increased surface area to volume 
ratio of  smaller particles, as well as properties such as shape, 
can all contribute to an increased bactericidal activity com-
pared to their corresponding metal ions (Gautam and Van 
Veggel, 2013; Rudramurthy et al., 2016). Zinc oxide nanopar-
ticles have been demonstrated as effective bactericidal agents 
against antibiotic resistant S.  aureus and Staphylococcus 
epidermidis (Ansari et  al., 2012). Silver nanoparticles have 
also been shown to be effective against bacterial and fungal 
species, including some important pathogens (Rudramurthy 
et al., 2016).
While in many respects metal nanoparticles may be a prom-
ising tool, use of this technology could also generate bacterial 
resistance. Strain-specific minimum inhibitory concentrations of 
nanoparticles in E. coli and S. aureus have already been identi-
fied, demonstrating that varied resistance to nanoparticle anti-
microbial mechanisms exist naturally in the bacterial population 
(Ruparelia et al., 2008). There is also the risk of accumulation 
of nanoparticles in livestock tissues particularly if these prod-
ucts are used over long time periods, and the implications for 
animal health and food safety are not yet completely under-
stood (Fondevila et al., 2009; De Jong et al., 2013; Adeyemi and 
Faniyan, 2014). Prior to use, it will be necessary to determine if  
interaction between a specific nanoparticle and biological tissues 
results in undesired degradation by-products, inflammation, or 
oxidative stress (Gautam and Van Veggel, 2013; Rudramurthy 
et al., 2016). Metal nanoparticles may be able to confer similar or 
improved benefits as antibiotic alternatives in livestock; however, 
more work needs to be done to fully understand their antimicro-
bial mechanisms, and impacts on tissues and the environment 
before they can be readily used in livestock production systems.
Organic Acids
Organic acids have been used in the food industry as pre-
servatives and disinfectants for many years, and more recently 
have gained interest as feed additives for livestock (Ricke, 2003; 
Upadhaya et  al., 2014). Some organic acids that have been 
tested include formic, acetic, sorbic, fumaric, lactic, propionic, 
citric, and benzoic acid. The proposed mode of action for 
organic acids involves conversion into their antibacterial forms 
in the gastrointestinal tract and diffusion into bacterial cells, 
decreasing cell internal pH (Ricke, 2003; Bearson et al., 1997).
Providing a mixture of organic acids to finisher pigs or broiler 
chicks has been shown to decrease E. coli counts and increase 
growth performance (Mohamed et al., 2014; Upadhaya et al., 
2014). Similarly, the addition of formic or propionic acid in a 
Salmonella infection model decreased cecal Salmonella counts 
in chicks at 7, 14, and 21  days of age (McHan and Shotts, 
2015). These effects on common pathogens suggest that organic 
acids could be a promising alternative to antibiotics; however, 
results are contradictory. In a different experiment, formic acid 
inclusion resulted in no effect on average daily gain of broiler 
chickens compared to a control diet, though changes in intes-
tinal morphology were observed (Garcia et al., 2007). It is still 
unclear whether organic acids can improve growth perfor-
mance and animal health across different livestock production 
settings, or if  their efficacy is reliant on certain external factors. 
In stored feed the concentration of organic acids required to 
decrease pathogens depends on feed composition and patho-
gen status; for example, bacteria in stationary phase may be 
more resistant (Ricke, 2003). In vivo, their efficacy depends in 
part on factors such as pH, where low pH allows more undisso-
ciated acid to remain intact and functional (Baik et al., 1996). 
Protection via encapsulation may also improve efficacy by sup-
plying acids to the intestine in their undissociated form and 
preventing absorption or metabolism before the products reach 
their desired location (Upadhaya et al., 2014).
Perhaps the most concerning drawback to the use of organic 
acids is their ability to induce acid tolerance responses in 
exposed bacteria. This tolerance response can result in the abil-
ity to withstand short-term exposure to pH as low as 3 (Baik 
et al., 1996). Over one generation, bacteria can increase toler-
ance to more extreme acid conditions (Ricke, 2003; Bearson 
et  al., 1997). Bacterial species, such as Salmonella, naturally 
encounter low pH as well as short-chain fatty acids as part of 
their transit of the gastrointestinal tract, and can cope with 
these stressors using RNA polymerase, sigma S dependant sys-
tems (Baik et al., 1996). This acid stress response can increase 
pathogen survival in the stomach or in phagosomes, leading to 
increased virulence in both Salmonella and pathogenic E. coli 
(Ricke, 2003; Bearson et  al., 1997). Acid tolerance has also 
been shown to increase shedding of E. coli O157:H7 in calves 
and mice (Price et al., 2000). Acid adaptation can also improve 
bacterial resistance to heat, salt, and H2O2, which could have 
serious implications for food safety and preservation (Bearson 
et al., 1997). Increased resistance to these other stressors may 
also lead to bacterial resistance to other antimicrobial alterna-
tives such as metal ions or nanoparticles, further decreasing the 
number of tools available to help maintain animal health.
Essential Oils
Extracted oils from the roots, seeds, leaves, bark, flowers, 
and fruits of plants contain complex mixtures of phenolic 
compounds known for their antimicrobial, anti-inflammatory, 
and antioxidants activities (Ayseli and Ipek Ayseli, 2016). The 
bioactive components in essential oils can modify both bacter-
ial and host cellular functions by interacting with cell wall com-
ponents and lipid membranes, which in the right conditions 
can lead to cell death (Omonijo et al., 2017). A major concern, 
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as with antibiotics, is that over time bacteria may adapt and 
become resistant to the active phenolic components.
Studies have evaluated the antibacterial activity of essential 
oils and purified phytogenic compounds on both pathogenic 
and gut commensal bacteria. Pathogenic bacteria are sensitive 
to an array of essential oils at concentrations ranging from 
0.02 to 0.7 g/L (Yang et al., 2015). Antimicrobial activity was 
assessed in 28 different essential oils by disk diffusion method 
on pathogenic S. enterica and on beneficial Lactobacillus plan-
tarum. From the evaluation, essential oils from oranges had the 
best selective antibacterial activity against pathogenic bacteria 
with diminished activity on beneficial species (Ambrosio et al., 
2017). Essential oils have been shown to inhibit multidrug-re-
sistant bacteria independently of their antibiotic resistance 
profile (Becerril et al., 2012). Antifungal properties have also 
been documented against multiple strains of Candida albi-
cans isolated from cattle with mastitis. Rosemary terpenes are 
suggested to act together on C. albicans by disrupting cellular 
integrity, respiration, ion transport, and membrane permea-
bility (Ksouri et  al., 2017). Similarly, citrus essential oils are 
suspected to disrupt the cell membrane due to the less abun-
dant compounds working synergistically rather than one dom-
inant compound such as thymol and carvacrol found in select 
herbal essential oils (Ambrosio et al., 2017). In this light, the 
antimicrobial mode of action of essential oils may be specific 
to one compound or the result of many.
The effectiveness of essential oils against common path-
ogens, E.  coli O157:H7 and S.  enterica, is dependent on the 
concentration of active phenolic compounds (Friedman et al., 
2017). A cause of concern comes from an outbreak of S. enter-
ica infections traced back to contaminated basil leaves. The 
subinhibitory concentrations of basil permitted S.  enterica 
to develop resistance to its active component linalool (Kisluk 
et al., 2013). Bacterial resistance mechanisms toward essential 
oils include selective membrane permeability, regulated efflux/
influx and chemotaxis-controlled motility (Kalily et al., 2016). 
Linalool-associated adaptations, although protective in vitro, 
may have a significant fitness cost on the adapted bacteria 
in a challenging environment (Kalily et  al., 2017). Bacteria-
associated adaptations complicate the use of essential oils 
and long-term studies are needed to understand whether the 
adapted resistance is a transmissible function.
Phytogenic compounds have good potential as an alternative 
to antibiotics in animal production, both as growth promoters 
and as treatment for bacterial infections (Omonijo et al., 2017; 
Reyer et al., 2017). Concentrations of the active components 
must be tested in vivo to determine whether an effective dose 
can be reasonably achieved. Additionally, their lipophilic nature 
may limit delivery to enteric pathogens, but again, microencap-
sulation for targeted release can help (Yang et al., 2015). A new 
strategy to combine essential oils with either disruptive metals, 
antibiotics, and/or nanotechnologies has gained attention to 
effectively combat multiresistant strains of bacteria and reduce 
bacterial resistance (Kwiatkowski et al., 2017; Low et al., 2017; 
Omonijo et al., 2017). The synergistic effect of phenolic com-
pounds in combination with other environmental challenging 
applications may be a safer and more effective approach to 
address growing concerns of bacterial resistance.
Microbial Approaches
Direct-fed microbials, or probiotics, have been evaluated as 
alternatives to antimicrobial growth promoters in livestock pro-
duction. The effectiveness of direct-fed microbials as growth 
promoters and therapeutic antimicrobials is highly variable 
(McAllister et al., 2011), but positive effects, such as improv-
ing feed efficiency, weight gain, nutrient digestibility, intestinal 
morphology, and reducing potential pathogens and diarrhea 
occurrence have been reported in livestock species (Salim et al., 
2013; Hou et al., 2015; Lei et al., 2015; Uyeno et al., 2015).
The strains selected for use as probiotics must be evaluated for 
the presence of antimicrobial resistance genes that could poten-
tially be transferred to pathogenic bacteria in the gut. Antibiotic 
susceptibility in 46 Lactobacillus strains obtained from the human 
gut and dairy products was evaluated by disc-diffusion method, 
and all strains had shown resistance to a group of 14 antibiotics 
(Charteris et al., 1998). One strain of Lactobacillus reuteri, a pro-
biotic candidate that can reduce E. coli and Salmonella pullorum 
growth in vitro, showed resistance to several antibiotics, includ-
ing tetracycline, chloramphenicol, vancomycin, streptomycin, 
bacitracin, and penicillin G (Zhang et al., 2012). Identification 
and removal of resistance determinants, creating mutants with 
similar probiotic capacities, can potentially be used as a strategy 
to overcome the risk of horizontal gene transfer from probiotics 
to pathogens (Rosander et al., 2008).
Several direct-fed microbial strains produce short-chain 
fatty acids, which can reduce gut pH and inhibit pathogen 
growth (Kamada et al., 2013). However, in vitro studies found 
that Listeria monocytogenes can develop tolerability to acidic 
conditions, which is associated with increased resistance to 
other stressors and increased virulence (O’Driscoll et al., 1996; 
Conte et al., 2000), and as discussed above.
A promising microbial approach that might replace or com-
plement antibiotic treatments is the use of purified bacterioc-
ins or bacteriocin-producing microorganisms (Cavera et  al., 
2015). Bacteriocins are peptides ribosomally synthesized by 
bacteria and archaea (Riley and Wertz, 2002; Cotter et  al., 
2005) that vary in size, structure, mechanism of action, anti-
microbial potency, immunity mechanisms, target cell receptors 
(Gillor et al., 2008), and bactericidal spectrum (Cotter et al., 
2005). Bacteriocins can facilitate the dominance of a producer 
in a competitive environment (Dawid et  al., 2007), regulate 
gut microbiota (Bhardwaj et al., 2010), and inhibit pathogen 
growth, without affecting others members of the microbial 
community (Dabour et al., 2009). The mechanisms by which 
bacteriocins exert their bactericidal and bacteriostatic effects 
include cell wall and plasma membrane disruption, impair-
ment of protein synthesis, interference with DNA replication 
and transcription, and induction of cell autolysis (Cavera et al., 
2015; Ahmad et al., 2017).
Bacteriocins can be used to treat infectious diseases such 
as mastitis caused by Streptococcus dysgalactiae in lactating 
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cows (Ryan et al., 1998), to preserve food products, and to pro-
mote the establishment of probiotic strains (Cotter et al., 2005; 
Cotter et al., 2013; Martinez et al., 2016). However, innate and/
or acquired resistance to bacteriocins are frequently reported 
(Ahmad et  al., 2017). Identified mechanisms of bacteriocin 
resistance in Gram positive bacteria include cell wall modi-
fications and alteration of the cell membrane composition, 
which affect membrane fluidity and electrical charges, therefore 
impairing bacteriocin ability to bind to bacterial cells. These 
mechanisms are similar to those of resistance to antibiotics, 
and this similarity raises concern regarding the development 
of cross-resistance (Zhou et  al., 2014). Bacteriocin-resistant 
L.  monocytogenes downregulate the expression of mannose 
phosphotransferase system, impairing the binding of bacteri-
ocins to the cell membrane; but this resistance is accompanied 
by a reduction in pathogen growth rate compared to the sen-
sitive strain (Masias et al., 2017), indicating that the develop-
ment of resistance to bacteriocins may increase energy costs 
and compromise fitness of resistant strains (Martinez et  al., 
2016). Some bacteriocins have been engineered for improved 
efficacy and stability (Cavera et al., 2015), and their use as ther-
apeutic agents is a rapidly developing area of research (Lohans 
and Vederas, 2012). However, there are currently only a few 
commercially bacteriocin-based products available for veteri-
nary use (Martinez et al., 2016).
Conclusion
It is clear that there is substantial effort going into the 
development of antibiotic alternatives to support healthy and 
efficient animal production. As we move forward with these 
technologies, it is important to keep resistance mechanisms in 
mind so that these technologies can be sustained. Most impor-
tantly, some of these antibiotic alternatives, such as zinc oxide, 
can clearly contribute to increased antibiotic resistance and 
should therefore be avoided. For other antibiotic alternatives, 
Figure 3. Antibiotic alternatives may be a danger in disguise.
Pig image: many antimicrobial alternatives target the early post-weaning piglet.
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such as phage and bacteriocins, the potential contribution to 
antibiotic resistance is less clear, but should be considered. 
The idea of using more specific antibiotic alternative therapies, 
such as bacteriophage and bacteriocins, is enticing, as they 
do not affect commensal microbes. Furthermore, new phage 
will always be available as a result of the constant arms race 
between bacteria and bacteriophage. Ultimately, any strategy 
used must be economically viable, but we must avoid compla-
cency and ensure that we are not replacing a wolf  (antibiotic 
resistance) with a wolf  in sheep’s clothing (Figure 3).
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